Catherine Lovegrove ESA-SRB-NZSE-CaSR 2026 in conjunction with ENSA

Catherine Lovegrove

Abstracts this author is presenting:

• CaSR Signalling, Mineral Metabolism, and Genetic Susceptibility to Kidney Stone Disease — CaSR-5 Session-7: Mineral Metabolism-2: CaSR and the kidney